INFLECTIS BIOSCIENCE
InFlectis BioScience is leveraging its leading expertise in the cellular defense system against misfolded proteins and drug discovery to identify and develop small molecules which modulate key proteins involved in misfolded protein disorders. Endoplasmic Reticulum (ER) proteostasis is vital for cellular function and cell survival. Many different perturbations can alter the folding capacity of the ER and may cause accumulation of unfolded or misfolded proteins inside the ER, a cellular condition referred to as ER stress. To safeguard proteostasis, the mammalian ER has a complex machinery to maintain the integrity of cells. This adaptive programme is called the unfolded protein response (UPR).
INFLECTIS BIOSCIENCE
Social Links:
Industry:
Biopharma Biotechnology Health Care Medical Pharmaceutical
Founded:
2013-01-01
Address:
Nantes, Pays De La Loire, France
Country:
France
Website Url:
http://www.inflectis-bioscience.com
Total Employee:
1+
Status:
Closed
Contact:
+330251252000
Email Addresses:
[email protected]
Total Funding:
7.75 M EUR
Current Employees Featured
Founder
Investors List
Participations Besancon
Participations Besancon investment in Series A - InFlectis BioScience
Crédit Mutuel Innovation
Crédit Mutuel Innovation investment in Series A - InFlectis BioScience
GO CAPITAL
GO CAPITAL investment in Series A - InFlectis BioScience
Remiges Ventures
Remiges Ventures investment in Series A - InFlectis BioScience
GO CAPITAL
GO CAPITAL investment in Seed Round - InFlectis BioScience
Official Site Inspections
http://www.inflectis-bioscience.com
Unable to get host informations!!!
